Abstract
We sequenced a novel conjugative blaKPC-2-harboring IncN plasmid, pYD626E, from an Escherichia coli sequence type 648 strain previously identified in Pittsburgh, Pennsylvania. pYD626E was 72,800 bp long and carried four β-lactamase genes, blaKPC-2, blaSHV-12, blaLAP-1, and blaTEM-1. In addition, it harbored qnrS1 (fluoroquinolone resistance) and dfrA14 (trimethoprim resistance). The plasmid profile and clinical history supported the in vivo transfer of this plasmid between Klebsiella pneumoniae and Escherichia coli.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Anti-Bacterial Agents / pharmacology
-
Bacterial Proteins / genetics*
-
Base Sequence
-
Carbapenems
-
Conjugation, Genetic / genetics
-
Drug Resistance, Multiple, Bacterial / genetics
-
Escherichia coli / drug effects
-
Escherichia coli / genetics*
-
Escherichia coli Proteins / genetics*
-
Fluoroquinolones
-
Humans
-
Klebsiella pneumoniae / drug effects
-
Klebsiella pneumoniae / genetics
-
Male
-
Microbial Sensitivity Tests
-
Molecular Sequence Data
-
Plasmids / genetics*
-
Sequence Analysis, DNA
-
Trimethoprim Resistance / genetics
-
beta-Lactamases / genetics*
Substances
-
Anti-Bacterial Agents
-
Bacterial Proteins
-
Carbapenems
-
Escherichia coli Proteins
-
Fluoroquinolones
-
Qnr protein, E coli
-
beta-Lactamases
-
carbapenemase